Home

BioLineRx Ltd. - American Depositary Shares (BLRX)

3.5600
-0.0100 (-0.28%)

Biolinerx Ltd is a biopharmaceutical company that focuses on the development of innovative therapies for cancer and other diseases

The company is engaged in the research and clinical development of a diverse pipeline of drug candidates, aiming to address unmet medical needs through cutting-edge technologies and unique approaches. Biolinerx collaborates with various academic institutions and industry partners to enhance its product offerings and accelerate the development of its therapeutic solutions, striving to improve patient outcomes and quality of life in the medical field.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close3.570
Open3.460
Bid3.500
Ask3.550
Day's Range3.240 - 3.560
52 Week Range0.0815 - 4.440
Volume205,189
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume20,336,443

News & Press Releases

Let's take a look at the stocks that are in motion in today's session.chartmill.com
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Via Chartmill · January 30, 2025
Top stock movements in today's session.chartmill.com
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via Chartmill · January 30, 2025
There are notable gap-ups and gap-downs in today's session.chartmill.com
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · January 30, 2025
Earnings Preview For BioLine Rxbenzinga.com
Via Benzinga · November 22, 2024
BLRX Stock Earnings: BioLine Rx Beats Revenue for Q2 2024investorplace.com
BLRX stock results show that BioLine Rx beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 15, 2024
Earnings Preview For BioLine Rxbenzinga.com
Via Benzinga · March 25, 2024
Nasdaq Surges Over 300 Points; State Street Earnings Top Viewsbenzinga.com
Via Benzinga · January 17, 2025
S&P 500 Gains 1%; Fastenal Posts Downbeat Earningsbenzinga.com
Via Benzinga · January 17, 2025
Dow Jumps Over 300 Points; US Industrial Production Beats Estimatesbenzinga.com
Via Benzinga · January 17, 2025
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · January 16, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 6, 2025
Nasdaq Surges Over 200 Points; BioLineRx Shares Plummetmarkets/com
Via Benzinga · January 6, 2025
S&P Jumps 1%; Regional Health Properties Shares Spike Highermarkets/com
Via Benzinga · January 6, 2025
US Stocks Open Higher; Dow Jumps Over 200 Pointsbenzinga.com
Via Benzinga · January 6, 2025
Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · January 3, 2025
Earnings Scheduled For November 25, 2024benzinga.com
Via Benzinga · November 25, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 21, 2024
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · October 11, 2024
Why Arcadium Lithium Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · October 7, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesdayinvestorplace.com
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning!
Via InvestorPlace · June 18, 2024
Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025investorplace.com
These 10X penny stocks have the potential to mint millionaires with enough capital but buy wisely as the risk is real.
Via InvestorPlace · June 5, 2024
BLRX Stock Earnings: BioLine Rx Beats EPS for Q1 2024investorplace.com
BLRX stock results show that BioLine Rx beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 28, 2024
BLRX Stock Earnings: BioLine Rx Beats EPS for Q4 2023investorplace.com
BLRX stock results show that BioLine Rx beat analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 26, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 26, 2024
Earnings Scheduled For March 26, 2024benzinga.com
Companies Reporting Before The Bell • bluebird bio (NASDAQBLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
Via Benzinga · March 26, 2024